NCT05460403 2022-07-15
Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection
ChineseAMS
Unknown
Clinical Trials
12 trialsNCT04014465 2021-02-02
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
ChineseAMS
Unknown
NCT02279134 2020-04-03
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
ChineseAMS
Phase 2/3 Unknown
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT01745107 2019-01-31
IMRT
ChineseAMS
Phase 3 Unknown
NCT03308552 2019-01-02
Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
ChineseAMS
Phase 3 Unknown
NCT02461043 2015-09-01
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 3 Unknown
NCT02319187 2015-08-03
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
ChineseAMS
Phase 3 Unknown
NCT02448966 2015-05-20
Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
ChineseAMS
Unknown
NCT02448979 2015-05-20
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
ChineseAMS
Phase 3 Unknown
NCT02355249 2015-02-04
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
ChineseAMS
Phase 3 Unknown
NCT01444547 2014-05-06
A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin
ChineseAMS
Phase 2 Unknown